Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rui

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cellsR A Kirken, R A Erwin, L Wang, et al.
Clinical and Experimental Obstetrics & Gynecology|May 11, 2018
Serum levels of the immunomodulatory protein, the progesterone induced blocking factor (PIBF) which is found in high levels during pregnancy is not higher in women with progesterone (P) receptor (R) positive vs. negative breast cancerJ H Check, A Rosenberg, D L Check, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemiaK Purvis, A Tollefsrud, H Rui, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1997
Chemoprevention of cancer of uterine cervix: a study on chemoprevention of retinamide II from cervical precancerous lesionsC Ruidi, D Aihua, B Peiyu, et al.
Endocrinology|October 28, 1999
Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ cultureT J Ahonen, P L Härkönen, J Laine, et al.
The Biochemical Journal|November 1, 1996
Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alphaM G Malabarba, H Rui, H H Deutsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1993
Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2J Y Djeu, J H Liu, S Wei, et al.
Cytokine|October 1, 1995
Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chainR A Kirken, H Rui, M G Malabarba, et al.
The Journal of Endocrinology|March 9, 2006
Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in miceF E Utama, M J LeBaron, L M Neilson, et al.
Oncogene|June 14, 2011
Inflammatory signaling compromises cell responses to interferon alphaW-C Huangfu, J Qian, C Liu, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cellsR A Kirken, R A Erwin, L Wang, et al.
Clinical and Experimental Obstetrics & Gynecology|May 11, 2018
Serum levels of the immunomodulatory protein, the progesterone induced blocking factor (PIBF) which is found in high levels during pregnancy is not higher in women with progesterone (P) receptor (R) positive vs. negative breast cancerJ H Check, A Rosenberg, D L Check, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemiaK Purvis, A Tollefsrud, H Rui, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1997
Chemoprevention of cancer of uterine cervix: a study on chemoprevention of retinamide II from cervical precancerous lesionsC Ruidi, D Aihua, B Peiyu, et al.
Endocrinology|October 28, 1999
Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ cultureT J Ahonen, P L Härkönen, J Laine, et al.
The Biochemical Journal|November 1, 1996
Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alphaM G Malabarba, H Rui, H H Deutsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1993
Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2J Y Djeu, J H Liu, S Wei, et al.
Cytokine|October 1, 1995
Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chainR A Kirken, H Rui, M G Malabarba, et al.
The Journal of Endocrinology|March 9, 2006
Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in miceF E Utama, M J LeBaron, L M Neilson, et al.
Oncogene|June 14, 2011
Inflammatory signaling compromises cell responses to interferon alphaW-C Huangfu, J Qian, C Liu, et al.
Pageof 10